10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2013 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | |
Sales to customers | $ 71,312 | 67,224 | 65,030 |
Cost of products sold | 22,342 | 21,658 | 20,360 |
Gross profit | 48,970 | 45,566 | 44,670 |
Selling, marketing and administrative expenses | 21,830 | 20,869 | 20,969 |
Research and development expense | 8,183 | 7,665 | 7,548 |
In-process research and development | 580 | 1,163 | 0 |
Interest income | (74) | (64) | (91) |
Interest expense, net of portion capitalized (Note 4) | 482 | 532 | 571 |
Other (income) expense, net | 2,498 | 1,626 | 2,743 |
Restructuring (Note 22) | 0 | 0 | 569 |
Earnings before provision for taxes on income | 15,471 | 13,775 | 12,361 |
Provision for taxes on income (Note 8) | 1,640 | 3,261 | 2,689 |
Net earnings | 13,831 | 10,514 | 9,672 |
Add: Net loss attributable to noncontrolling interest | 0 | 339 | 0 |
Net earnings attributable to Johnson & Johnson | 13,831 | 10,853 | 9,672 |
Net earnings per share attributable to Johnson & Johnson (Notes 1 and 15) | |||
Basic | 4.92 | 3.94 | 3.54 |
Diluted | 4.81 | 3.86 | 3.49 |
Cash dividends per share | 2.59 | 2.40 | 2.25 |
Average shares outstanding (Notes 1 and 15) | |||
Basic | 2,809,200 | 2,753,300 | 2,736,000 |
Diluted | 2,877,000 | 2,812,600 | 2,775,300 |
External Links | |
JOHNSON & JOHNSON (JNJ) Fiscal Year 2013 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |